ABBV Jan 2026 230.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:25AM EDT. Market open.
Loading interactive chart…
- PR Newswire
AbbVie Presents New Data Supporting Leading Gastroenterology Portfolio at 2024 Digestive Disease Week®
AbbVie (NYSE: ABBV) announced it is presenting 15 abstracts at the 2024 Digestive Disease Week (DDW) Annual Meeting, being held May 18-21 in Washington, D.C., and virtually.
- Zacks
Are You Looking for a High-Growth Dividend Stock?
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes? Let's find out.
- Zacks
AbbVie (ABBV) Boosts Neuropsychiatric Portfolio With New Deal
AbbVie (ABBV) inks an option-to-license and collaboration deal with Gilgamesh to develop next-generation therapies for psychiatric disorders.
© 2024 Yahoo. All rights reserved.